v3.26.1
SHAREHOLDERS' EQUITY (Details Textual) - USD ($)
1 Months Ended 3 Months Ended
Jan. 06, 2026
Jan. 07, 2025
Feb. 24, 2026
Jan. 30, 2026
Mar. 31, 2026
Mar. 31, 2025
Feb. 23, 2026
Dec. 31, 2025
Shareholders' Equity                
Reverse share split, description a reverse share split of the Company’s ordinary shares within a range of 1-for-2 to 1-for-12, to be effective at the ratio   one-for-twelve reverse share split of its ordinary shares. As a result of the reverse share split, every twelve issued and outstanding ordinary shares were automatically combined and converted into one ordinary share one-for-twelve reverse share split of the Company’s ordinary shares        
Common stock, shares, issued     1,528,207   2,826,473   18,339,098 1,572,319
Common stock, shares, outstanding     1,528,207   2,778,585   18,339,098 1,524,431
Common stock, shares authorized     100,000,000   100,000,000   75,000,000 75,000,000
Maximum number of authorized ordinary shares reverse share split 100,000,000              
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term         6 years 29 days      
Number of share-based outstanding         265,139     52,450
weighted average grant date fair value         $ 6.53      
Certain institutional purchasers [Member] | Registered direct offering of ordinary shares in July 2020 [Member]                
Shareholders' Equity                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights         42,834      
Proceeds from Warrant Exercises         $ 4,821,416      
Certain institutional purchasers [Member] | Offering of ordinary shares in December 2020 [Member]                
Shareholders' Equity                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights         2,690      
Proceeds from Warrant Exercises         $ 405,003      
Purchase agreement with certain institutional investors [Member]                
Shareholders' Equity                
Offering price per share   $ 33            
Issuance of ordinary shares, net of issuance expenses, shares   151,515            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   151,514            
Purchase agreement for issuance and sale of ordinary shares and ordinary warrants                
Shareholders' Equity                
Exercise price per share   $ 33            
H.C. Wainwright & Co. LLC | Purchase agreement with certain institutional investors [Member]                
Shareholders' Equity                
Exercise price per share   $ 41.25            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   9,088            
Affiliated Entity [Member] | Incentive Compensation Plan 2025 [Member]                
Shareholders' Equity                
Shares reserved for future issuance (in shares)           224,439,000   39,851,000
Employee Stock Option [Member]                
Shareholders' Equity                
Unrecognized cost of shares         $ 2,500,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term         3 years 4 months 24 days      
Employee and Non-Employee RSUs [Member]                
Shareholders' Equity                
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value         $ 6.53 $ 0    
Granted         45,941